Mr Troy Anthony Day, in Hockessin, DE - Occupational Therapist

Mr Troy Anthony Day, is a Occupational Therapist based in Hockessin, Delaware. Mr Troy Anthony Day is licensed to practice in Delaware (license number U1-001823) and his current practice location is 100 Saint Claire Dr, Hockessin, Delaware. He can be reached at his office (for appointments etc.) via phone at (302) 234-4107.

NPI number for Mr Troy Anthony Day is 1477072544 and his current mailing address is 8790 Highland St, Port Norris, New Jersey. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1477072544.

Contact Information

	Mr Troy Anthony Day,
	100 Saint Claire Dr, Hockessin, DE 19707-8906
	(302) 234-4107
	Not Available

Healthcare Provider's Profile

Full Name	Mr Troy Anthony Day
Gender	Male
Speciality	Occupational Therapist
Location	100 Saint Claire Dr, Hockessin, Delaware
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1477072544
Provider Enumeration Date: 09/11/2017
Last Update Date: 09/11/2017

Medical Identifiers

Medical identifiers for Mr Troy Anthony Day such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1477072544	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	U1-001823 (Delaware)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Troy Anthony Day is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Troy Anthony Day, 8790 Highland St, Port Norris, NJ 08349-3416 Ph: (856) 265-3016	Mr Troy Anthony Day, 100 Saint Claire Dr, Hockessin, DE 19707-8906 Ph: (302) 234-4107

News Archive

Getting back to normal in Germany after coronavirus pandemic

The coronavirus disease (COVID-19) global pandemic is wreaking havoc across the globe, affecting 1.85 million people and has killed more than 114,000 people. The respiratory illness, akin to the SARS and MERS epidemics in the past, is infectious and dangerous to vulnerable populations, such as older adults and those with underlying health conditions.

Medicine-loaded nanoparticles could help patients achieve corneal transplant success

There are about 48,000 corneal transplants done each year in the U.S., compared to approximately 16,000 kidney transplants and 2,100 heart transplants. Out of the 48,000 corneal transplants done, 10 percent of them end up in rejection, largely due to poor medication compliance. This costs the health care system and puts undue strain on clinicians, patients and their families.

Daily use of Pycnogenol may help improve overall cognitive function

New research delivers exciting news for those seeking natural ways to boost memory and mental performance. A study recently published in the Journal of Neurosurgical Sciences shows daily use of Pycnogenol (pic-noj-en-all), a natural plant extract from French maritime pine tree bark, may help improve attention span, memory, decision-making – including executive-level performance – and overall cognitive function.

Altheos to fund development of ATS907 Rho-kinase inhibitor with completed $20M Series A financing

Altheos, Inc., a privately held early-stage biopharmaceutical company, announced today that it has completed a $20 million Series A financing led by Bay City Capital. New investors Novo A/S, Canaan Partners, Life Science Angels and Atheneos Capital also joined the round. The financing will be used primarily for the development of ATS907, a selective Rho-kinase inhibitor Altheos licensed from Japanese pharmaceutical company Asahi Kasei Pharma. The license also includes a series of highly active compounds (AK138 series) specifically for topical treatment for glaucoma.

Hesperos receives SBIR grant to create ‘human-on-a-chip' model to mimic Alzheimer's disease

Hesperos, Inc., announced today the receipt of a NIH Phase I Small Business Innovation Research grant from the National Institutes of Health National Institute on Aging to help create a new multi-organ "human-on-a-chip" model that can realistically mimic the biology of Alzheimer's Disease and the effects of potential new therapies under realistic human physiological conditions.

Occupational Therapist in Hockessin, DE

Emily Fazio, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6525 Lancaster Pike, Hockessin, DE 19707 Phone: 302-998-0181
Alexandra Thomas, DROT, ORT/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 806 Christopher Ct, Hockessin, DE 19707 Phone: 302-824-1675
Mrs. Priya Angela Devotta, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6677 Lancaster Pike, Hockessin, DE 19707 Phone: 302-239-3200
Kaitlin Mccormick, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6525 Lancaster Pike, Hockessin, DE 19707 Phone: 302-998-0181
Mrs. Jillian Marie Mcnulty, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 116 S Colts Neck Way, Hockessin, DE 19707 Phone: 609-922-2687 Fax: 609-922-2687
Elisha Omar, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 249 Peoples Way, Hockessin, DE 19707 Phone: 302-743-1495

Mr Troy Anthony Day, - Occupational Therapist in Hockessin, DE